Published August 1, 2009 | Version Accepted Version + Supplemental Material
Journal Article Open

Evaluation of structurally diverse neuronal nicotinic receptor ligands for selectivity at the α6 subtype

  • 1. ROR icon Catalyst Biosciences (United States)
  • 2. ROR icon University of Colorado Boulder
  • 3. ROR icon California Institute of Technology

Abstract

Direct comparison of pyridine versus pyrimidine substituents on a small but diverse set of ligands indicates that the pyrimidine substitution has the potential to enhance affinity and/or functional activity at α6 subunit-containing neuronal nicotinic receptors (NNRs) and decrease activation of ganglionic nicotinic receptors, depending on the scaffold. The ramifications of this structure–activity relationship are discussed in the context of the design of small molecules targeting smoking cessation.

Additional Information

© 2009 Elsevier Ltd. Received 16 March 2009; revised 15 May 2009; accepted 20 May 2009. Available online 27 May 2009. This work was supported by NCDDG grant DA019375 from the National Institutes of Health to H.A.L., M.J.M. and M.B.

Attached Files

Accepted Version - nihms-128262.pdf

Supplemental Material - mmc1.doc

Files

nihms-128262.pdf

Files (950.5 kB)

Name Size
md5:391279c1293a1c04b9c02234baa11dca
36.9 kB Download
md5:12bac4b12b2f7cf69eb242f14bf13649
913.6 kB Preview Download

Additional details

Identifiers

PMCID
PMC6107347
Eprint ID
14738
Resolver ID
CaltechAUTHORS:20090730-103918926

Funding

NIH
DA019375

Dates

Created
2009-08-07
Created from EPrint's datestamp field
Updated
2021-11-08
Created from EPrint's last_modified field